A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis

Title
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume 102, Issue 1, Pages 94-102
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2016-09-16
DOI
10.3324/haematol.2016.148924

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started